Lv1
60 积分 2024-12-05 加入
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1天前
已完结
Lupus nephritis-related chronic kidney disease
3天前
已完结
Effector and regulatory B cells in immune-mediated kidney disease
23天前
已完结
CAR T-Cell Therapy for Rheumatic Diseases: What Does the Future Hold?
24天前
已完结
Clinical efficacy and autoantibody seroconversion with CD19-CAR T cell therapy in a patient with rheumatoid arthritis and coexisting myasthenia gravis
2个月前
已完结
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
2个月前
已完结
CD19-targeting CAR-T cell treatment in patients with diffuse systemic sclerosis
2个月前
已完结
Antigen-specific immunotherapies for autoimmune disease
3个月前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
3个月前
已完结
Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression
3个月前
已完结
皖公网安备34019202002308
